Warren Buffett - Berkshire Hathaway 13F Activity & Position Changes (Q3 2021)
According to the SEC 13F filed on Nov 15, 2021, the Berkshire Hathaway portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2021, the filing reported:
New Buys - Floor & Decor Holdings, Inc., Royalty Pharma
Increases - Chevron Corporation
Reductions - AbbVie Inc., Bristol-Myers Squibb Company, Charter Communications, Inc., Mastercard Incorporated, Marsh & McLennan Companies, Inc, and 2 more
Complete Exits - Merck & Company, Inc., Organon & Co.
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2021
|
ABBV
AbbVie Inc.
|
Sell |
-6,129,373
|
|
Q3 2021
|
BMY
Bristol-Myers Squibb Company
|
Sell |
-4,247,330
|
|
Q3 2021
|
CHTR
Charter Communications, Inc.
|
Sell |
-1,012,835
|
|
Q3 2021
|
CVX
Chevron Corporation
|
Buy |
+5,579,599
|
|
Q3 2021
|
FND
Floor & Decor Holdings, Inc.
|
Buy - Position Entry |
+816,863
|
|
Q3 2021
|
MA
Mastercard Incorporated
|
Sell |
-276,108
|
|
Q3 2021
|
MMC
Marsh & McLennan Companies, Inc
|
Sell |
-1,454,937
|
|
Q3 2021
|
MRK
Merck & Company, Inc.
|
Sell - Position Exit |
-9,157,192
|
|
Q3 2021
|
OGN
Organon & Co.
|
Sell - Position Exit |
-1,550,481
|
|
Q3 2021
|
RPRX
Royalty Pharma
|
Buy - Position Entry |
+13,145,902
|
|
Q3 2021
|
USB
U.S. Bancorp
|
Sell |
-2,471,019
|
|
Q3 2021
|
V
Visa Inc.
|
Sell |
-425,000
|